• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, February 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Testosterone is an ally of macrophages in the battle against adrenal cancers

Bioengineer by Bioengineer
October 14, 2022
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Why are cancers of the adrenal glands1 more common among women? Why are prognoses worse for them? A team of scientists led by a CNRS researcher answers these questions in an article published on 14 October 2022 in Science Advances. They demonstrate that, in male mice, there is greater recruitment of immune cells known as macrophages, which can eliminate tumour cells. Hence, aggressive tumour progression is scarcely seen in male mice; while in female miles, macrophages do not slow the growth of tumours, which eventually metastasize. Through molecular analyses, the team determined that recruitment of tumour-fighting macrophages depends on testosterone. After simple administration of the hormone to females, macrophages able to eradicate tumour cells were rallied to battle. On the basis of these findings, the scientists conducted another study using data on humans, which revealed the same difference in macrophage recruitment rates between men and women with adrenal cancers.  This discovery suggests the potential of hormonal stimulation as a treatment for this type of cancer, whose five-year survival rate is less than 30%.

Macrophages attacking adrenal tumour in male mouse.

Credit: © Julie Olabe CNRS/GReD

Why are cancers of the adrenal glands1 more common among women? Why are prognoses worse for them? A team of scientists led by a CNRS researcher answers these questions in an article published on 14 October 2022 in Science Advances. They demonstrate that, in male mice, there is greater recruitment of immune cells known as macrophages, which can eliminate tumour cells. Hence, aggressive tumour progression is scarcely seen in male mice; while in female miles, macrophages do not slow the growth of tumours, which eventually metastasize. Through molecular analyses, the team determined that recruitment of tumour-fighting macrophages depends on testosterone. After simple administration of the hormone to females, macrophages able to eradicate tumour cells were rallied to battle. On the basis of these findings, the scientists conducted another study using data on humans, which revealed the same difference in macrophage recruitment rates between men and women with adrenal cancers.  This discovery suggests the potential of hormonal stimulation as a treatment for this type of cancer, whose five-year survival rate is less than 30%.

 

1Le corps humain compte deux glandes surrénales, chacune située au-dessus d’un rein. Elles secrètent des hormones telles que l’adrénaline (participant, entres autres, au contrôle de la tension artérielle, de la fréquence cardiaque ou de la transpiration), des corticoïdes (impliqués dans le contrôle de la tension artérielle, des taux de sel et de potassium dans l’organisme et du métabolisme des sucres et des graisses), et des androgènes.



Journal

Science Advances

DOI

10.1126/sciadv.add0422

Article Title

Sexually dimorphic activation of innate antitumour immunity prevents adrenocortical carcinoma development

Article Publication Date

14-Oct-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Brooke Emerling, Ph.D.

New treatment approach for prostate cancer could stop resistance in its tracks

February 3, 2023
MOU signing

MD Anderson announces new collaboration in Indonesia to reduce global cancer burden

February 3, 2023

Genes & Cancer | Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

February 3, 2023

HKUMed discovers a new tumour suppressive gene which boosts personalised treatment response in breast cancer

February 3, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Black South Africans report higher life satisfaction and are at less risk for depression post-migration, MU study finds

New treatment approach for prostate cancer could stop resistance in its tracks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In